Deals
Merck KGaA Revives Sale of Allergy Therapy Business
This article is for subscribers only.
Merck KGaA is reviving plans for a potential sale of its allergy business, people with knowledge of the matter said.
The German pharmaceutical company is working with an adviser to consider options for the Allergopharma business, according to the people, who asked not to be identified because the information is private.